stella
beta
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma — Stella
Recruiting
Back to Recurrent Grade 1 Follicular Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
City of Hope Medical Center, Duarte, California
City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California
View full record on ClinicalTrials.gov